
|Videos|April 19, 2022
Clinical Factors Impacting Risk Assessment, Prognosis, and Progression
Author(s)Srdan Verstovsek, MD, PhD
A focused discussion on the clinical factors that impact patient prognosis, risk assessment, and disease progression.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5








































